Insulin-producing organoids engineered ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes.
Auteur(s) :
Lebreton, Fanny [Auteur]
Lavallard, Vanessa [Auteur]
Bellofatto, Kevin [Auteur]
Bonnet, Romain [Auteur]
Wassmer, Charles H. [Auteur]
Perez, Lisa [Auteur]
Kalandadze, Vakhtang [Auteur]
Follenzi, Antonia [Auteur]
Boulvain, Michel [Auteur]
Pattou Kerr-Conte, Julie [Auteur]
Recherche translationnelle sur le diabète (RTD) - U1190
Goodman, David J. [Auteur]
Bosco, Domenico [Auteur]
Bernez, Thierry [Auteur]
Berishvili, Ekaterine [Auteur]
Lavallard, Vanessa [Auteur]
Bellofatto, Kevin [Auteur]
Bonnet, Romain [Auteur]
Wassmer, Charles H. [Auteur]
Perez, Lisa [Auteur]
Kalandadze, Vakhtang [Auteur]
Follenzi, Antonia [Auteur]
Boulvain, Michel [Auteur]
Pattou Kerr-Conte, Julie [Auteur]

Recherche translationnelle sur le diabète (RTD) - U1190
Goodman, David J. [Auteur]
Bosco, Domenico [Auteur]
Bernez, Thierry [Auteur]
Berishvili, Ekaterine [Auteur]
Titre de la revue :
Nature Communications
Nom court de la revue :
Nat Commun
Numéro :
10
Pagination :
4491
Date de publication :
2019-10-03
ISSN :
2041-1723
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show ...
Lire la suite >Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show that viable and functional islet organoids can be successfully generated from dissociated islet cells (ICs) and human amniotic epithelial cells (hAECs). Incorporation of hAECs into islet organoids markedly enhances engraftment, viability and graft function in a mouse type 1 diabetes model. Our results demonstrate that the integration of hAECs into islet cell organoids has great potential in the development of cell-based therapies for type 1 diabetes. Engineering of functional mini-organs using this strategy will allow the exploration of more favorable implantation sites, and can be expanded to unlimited (stem-cell-derived or xenogeneic) sources of insulin-producing cells.Lire moins >
Lire la suite >Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show that viable and functional islet organoids can be successfully generated from dissociated islet cells (ICs) and human amniotic epithelial cells (hAECs). Incorporation of hAECs into islet organoids markedly enhances engraftment, viability and graft function in a mouse type 1 diabetes model. Our results demonstrate that the integration of hAECs into islet cell organoids has great potential in the development of cell-based therapies for type 1 diabetes. Engineering of functional mini-organs using this strategy will allow the exploration of more favorable implantation sites, and can be expanded to unlimited (stem-cell-derived or xenogeneic) sources of insulin-producing cells.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Date de dépôt :
2024-01-19T23:42:13Z
2024-09-25T12:20:12Z
2024-09-25T12:20:12Z
Fichiers
- s41467-019-12472-3.pdf
- Non spécifié
- Accès libre
- Accéder au document